SCHEMBL23905917

SCHEMBL23905917

C[C@]1(C#N)COc2c1cc(C(O)(CNC(=O)c1cc(OC3CC3)c3ncc(F)cc3c1)C(F)(F)F)nc2-c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23905259 0.89 GABRA5 (0.32) GABRA5
SCHEMBL23905771 0.89 IKBKE (0.31)
SCHEMBL24987243 0.89 GABRA5 (0.34) GABRA5
SCHEMBL23905348 0.88 GABRA5 (0.32) GABRA5
SCHEMBL23904836 0.87 GABRA5 (0.30) GABRA5
SCHEMBL23905522 0.87 CFTR (0.33) GABRA5
SCHEMBL25116292 0.86 GPR6 (0.33)
SCHEMBL23905343 0.86 IP6K1 (0.31)
SCHEMBL24987242 0.86 GABRA5 (0.32) GABRA5
SCHEMBL23905489 0.86 GABRA5 (0.33) GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed